RIPK1 and amyotrophic lateral sclerosis: Previous studies have demonstrated that RIP1 kinase activation also leads to neuroinflammation in multiple central nervous system (CNS) diseases such as Alzheimer′s disease (AD)19 and amyotrophic lateral sclerosis (ALS)20.